BridgeMD
Magnesiumsulphate for Postoperative Analgesia In the Newly delivered, The MAG-PAIN randomized controlled trial.
EU CTIS ID: 2024-519617-56-00
What this study is testing
The aim in this study is to investigate if adding intravenous magnesium-sulfate to pregnant women undergoing cesarean section can lead to improved postoperative pain outcomes.
- Therapeutic exploratory (Phase II)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Adult over age 18. Cesarean section under spinal anesthesia. Participant should be able to accomodate information in Swedish
You likely can't join if
- Cronic kidney desease stadium 3 or above. Not Swedish speaking. Contraindication towards spinal anesthesia. General anesthesia
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18-64 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.